skip to main content
US FlagAn official website of the United States government
dot gov icon
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
https lock icon
Secure .gov websites use HTTPS
A lock ( lock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.


Search for: All records

Creators/Authors contains: "Alo, R"

Note: When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external site maintained by the publisher. Some full text articles may not yet be available without a charge during the embargo (administrative interval).
What is a DOI Number?

Some links on this page may take you to non-federal websites. Their policies may differ from this site.

  1. COVID-19, known as Coronavirus Disease 2019, is a major health issue resulting from novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Its emergence has posed a significant menace to the global medical community and healthcare system across the world. Notably, on December 12, 2020, the Food and Drug Administration (FDA) approved the utilization of the Pfizer and Moderna COVID-19 vaccines. As of July 31, 2022, the United Stated has witnessed over 91.3 million cases of COVID-19 and nearly 1.03 million fatalities. An intriguing observation is the recent reduction in the mortality rate of COVID-19, attributed to an augmented focus on early detection, comprehensive screening, and widespread vaccination. Despite this positive trend in some demographics, it is noteworthy that the overall incidence rates of COVID-19 among African American and Hispanic populations have continued to escalate, even as mortality rates have decreased. Therefore, the objective of this research study is to present an overview of COVID-19, spotlighting the disparities among different racial and ethnic groups. It also delves into the management of COVID-19 within the minority populations. To reach our research objective, we used a publicly available COVID-19 dataset from kaggle: https://www.kaggle.com/datasets/paultimothymooney/covid19-casesand- deaths-by-race. In addition, we obtained COVID-19 datasets from 10 different states with the highest proportion of African American populations. Many considerable strikes have been made in COVID-19. However, success rate of treatment in the African American population remains relatively limited when compared to other ethnic groups. Hence, there arises a pressing need for novel strategies and innovative approaches to not only encourage prevention measures against COVID-19, but also to increase survival rates, diminish mortality rates, and ultimately improve the health outcomes of ethnic and racial minorities. 
    more » « less
  2. null (Ed.)
    Abstract—Networks have entered the mainstream lexicon over the last ten years. This coincides with the pervasive use of networks in a host of disciplines of interest to industry and academia, including biology, neurology, genomics, psychology, social sciences, economics, psychology, and cyber-physical systems and infrastructure. Several dozen journals and conferences regularly contain articles related to networks. Yet, there are no general purpose cyberinfrastructures (CI) that can be used across these varied disciplines and domains. Furthermore, while there are scientific gateways that include some network science capabilities for particular domains (e.g., biochemistry, genetics), there are no general-purpose network-based scientific gateways. In this work, we introduce net.science, a CI for Network Engineering and Science, that is designed to be a community resource. This paper provides an overview of net.science, addressing key requirements and concepts, CI components, the types of applications that our CI will support, and various dimensions of our evaluation process. Index Terms—cyberinfrastructure, network science, net.science 
    more » « less